Carotid intima-media thickness in low-risk individuals with asymptomatic atherosclerosis: Baseline data from the METEOR study

Current Medical Research and Opinion

Volumn 23, Issue 3, 2007, Pages 641-648

  Crouse III, John R ^a,e   Grobbee, Diederick E ^b   O'Leary, Daniel H ^c   Bots, Michiel L ^b   Evans, Gregory W ^a   Palmer, Mike K ^d   Riley, Ward A ^a   Raichlen, Joel S ^d  

^a WAKE FOREST UNIVERSITY   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c Carney Hospital   (United States)

^d ASTRAZENECA   (United Kingdom)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Baseline comparison; Carotid intima media thickness; Europe; USA

Indexed keywords

PLACEBO; ROSUVASTATIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CLINICAL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTIMA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; SYMPTOMATOLOGY; TUNICA MEDIA;

AGE FACTORS; AGED; BODY MASS INDEX; CAROTID ARTERY, COMMON; CAROTID STENOSIS; CORONARY ARTERIOSCLEROSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EUROPE; FEMALE; FLUOROBENZENES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; PROGNOSIS; PYRIMIDINES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SULFONAMIDES; SURVIVAL ANALYSIS; TUNICA INTIMA; TUNICA MEDIA; UNITED STATES;

EID: 33947366774     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X178711     Document Type: Article

References (21)

1. The World Health Organization. Reducing risks, promoting healthy life. The World Health Report 2002. Geneva: World Health Organization, 2002
2. Petersen S, Peto V, Rayner M, et al. European cardiovascular disease statistics. London: BHF, 2005
3. American Heart Association. Heart Disease and Stroke Statistics - 2004 Update. Dallas (TX): American Heart Association, 2003
4. Hoyert DL, Kung HC, Smith BL. Deaths: Preliminary data for 2003. Hyattsville (MD): NVSR, 2005:53
5. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003;24:1601-10
6. Raggi P. The use of electron-beam computed tomography as a tool for primary prevention. Am J Cardiol 2001;88:28J-32J
7. Kannel WB, Doyle JT, McNamara PM, et al. Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 1975;51:606-13
8. Pignoli P, Tremolli E, Poli A, et al. Intimal plus media thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986;74:1399-406
9. Wattanakit K, Folsom AR, Chambless LE, Nieto FJ. Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2005;149: 606-12
10. Dijk JM, van der Graaf Y, Bots ML, et al. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study. Eur Heart J 2006;27:1971-8
11. Espeland MA, O'Leary DH, Terry JG, et al. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med 2005;6:3
12. Bots ML. Carotid intima-media thickness as a surrogate marker for cardiovascular disease in intervention studies. Curr Med Res Opin 2006;22:2181-90
13. Crouse JR 3rd, Grobbee DE, O'Leary DH, et al. Measuring effects on intima media thickness: an evaluation of rosuvastatin in subclinical atherosclerosis - the rationale and methodology of the METEOR study. Cardiovasc Drugs Ther 2004;18: 231-8
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97
15. Rawson ES, Freedson PS, Osganian SK, et al. Body mass index, but not physical activity, is associated with C-reactive protein. Med Sci Sports Exerc 2003;35:1160-6
16. Guldiken S, Demir M, Arikan E, et al. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: soluble CD40 ligand and high-sensitivity C-reactive protein. Thromb Res 2007;119: 79-84
17. Howard G, Sharrett AR, Heiss G, et al. Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1993;24:1297-304
18. Iglesias del Sol A, Bots ML, Grobbee DE, et al. Carotid intima-media thickness at different sites: relation to incident myocardial infarction; The Rotterdam Study. Eur Heart J 2002;23:934-40
19. Stensland-Bugge E, Bonaa KH, Joakimsen O. Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis: the Tromso study. Atherosclerosis 2001;154:437-48
20. O'Leary DH, Polak JF, Kronmal RA, et al. Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke 1996;27:224-31
21. Walldius G, Jungner I, Holme I, et al. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet 2001;358:2026-33